C-C Motif Ligand 11 Reduction in CLL Patients Serum After Vitamin D Supplementation

Overview

Journal Hematology

Specialty Hematology

Date 2016 Feb 24

PMID 26902783

Citations 2

Authors

Marcin Kubeczko

Elzbieta Nowara

Dobromila Karwasiecka

Grazyna Siewior

Paulina Czajka-Francuz

Jerzy Chudek

Jerzy Wojnar

Affiliations

Soon will be listed here.

Abstract

Background: Vitamin D (VD) deficiency results in a worse prognosis in patients with chronic lymphocytic leukemia (CLL) and may affect the production of cytokines. Nonetheless, there is the lack of studies dealing with VD supplementation and its impact on chemokines in CLL patients.

Aim: The primary endpoint of our interventional study was to evaluate the effect of cholecalciferol supplementation on serum chemokines levels in CLL patients.

Materials And Methods: Eighteen subjects with CLL were enrolled for the study. Six-month-long cholecalciferol supplementation was performed in CLL patients with serum 25-OH-D3 levels below 30 ng/ml. Cytokines levels were assessed at the beginning of the study and after 6 months. Baseline measurements of cytokines were compared to those in apparently healthy controls.

Results: Increased levels of CCL2, CCL3, CCL4, CXCL8, CXCL10, TNFα, bFGF, G-CSF, and VEGF were found in CLL patients in comparison with the healthy controls. In the course of the VD supplementation a decrease in serum levels of chemokines CCL11, CCL3, and cytokine PDGF-BB was observed. The decrease of CCL11 was found in CLL patients on VD supplementation solely, whereas the decrease of CCL3 and PDGF-BB was observed in CLL subjects on both chemotherapy and VD supplementation.

Conclusion: The VD supplementation may exert beneficial effect on chemokines levels in CLL patients with VD deficiency.

Citing Articles

Integrative Hematology: State of the Art.

Andreazzoli F, Bonucci M Int J Mol Sci. 2023; 24(2).

PMID: 36675247 PMC: 9864076. DOI: 10.3390/ijms24021732.

The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia.

Gerousi M, Psomopoulos F, Kotta K, Tsagiopoulou M, Stavroyianni N, Anagnostopoulos A Cancers (Basel). 2021; 13(2).

PMID: 33466695 PMC: 7828837. DOI: 10.3390/cancers13020285.

References

Pludowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokol D, Czech-Kowalska J . Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013; 64(4):319-27. DOI: 10.5603/ep.2013.0012. View

Maj E, Filip-Psurska B, Switalska M, Kutner A, Wietrzyk J . Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model. Int J Mol Sci. 2015; 16(11):27191-207. PMC: 4661874. DOI: 10.3390/ijms161126016. View

Hyodo H, Kimura A, Nakata Y, Ohta H, Kuramoto A . 1 alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts. Int J Hematol. 1993; 57(2):131-7. View

Ten Hacken E, Burger J . Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment. Biochim Biophys Acta. 2015; 1863(3):401-413. PMC: 4715999. DOI: 10.1016/j.bbamcr.2015.07.009. View

Miyagaki T, Sugaya M, Fujita H, Ohmatsu H, Kakinuma T, Kadono T . Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. J Invest Dermatol. 2010; 130(9):2304-11. DOI: 10.1038/jid.2010.128. View

Trimarco V, Ave E, Facco M, Chiodin G, Frezzato F, Martini V . Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival. Oncotarget. 2015; 6(39):42130-49. PMC: 4747215. DOI: 10.18632/oncotarget.6239. View

Ho C, Hsu L, Phyliky R, Li C . Autocrine expression of platelet-derived growth factor B in B cell chronic lymphocytic leukemia. Acta Haematol. 2005; 114(3):133-40. DOI: 10.1159/000087886. View

Kelly J, Salles G, Goldman B, Fisher R, Brice P, Press O . Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies. J Clin Oncol. 2015; 33(13):1482-90. PMC: 4404425. DOI: 10.1200/JCO.2014.57.5092. View

Molica S, Vitelli G, Levato D, Gandolfo G, Liso V . Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. Br J Haematol. 1999; 107(3):605-10. DOI: 10.1046/j.1365-2141.1999.01752.x. View

10.

Miyagaki T, Sugaya M, Murakami T, Asano Y, Tada Y, Kadono T . CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation. Cancer Res. 2011; 71(6):2056-65. DOI: 10.1158/0008-5472.CAN-10-3764. View

11.

Bischoff-Ferrari H, Dawson-Hughes B, Stocklin E, Sidelnikov E, Willett W, Edel J . Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J Bone Miner Res. 2011; 27(1):160-9. DOI: 10.1002/jbmr.551. View

12.

Chiorazzi N, Rai K, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med. 2005; 352(8):804-15. DOI: 10.1056/NEJMra041720. View

13.

Jiang W, Gu H, Zhang Y, Xia Q, Qi J, Chen J . Vitamin D Supplementation in the Treatment of Chronic Heart Failure: A Meta-analysis of Randomized Controlled Trials. Clin Cardiol. 2015; 39(1):56-61. PMC: 6490747. DOI: 10.1002/clc.22473. View

14.

Yoon J, Lafarge S, Dawe D, Lakhi S, Kumar R, Morales C . Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2012; 53(9):1735-42. DOI: 10.3109/10428194.2012.666662. View

15.

Molica S, Digiesi G, Antenucci A, Levato L, Mirabelli R, Molica M . Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL). Leuk Res. 2011; 36(4):443-7. DOI: 10.1016/j.leukres.2011.10.004. View

16.

Bao B, Yao J, Lee Y . 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis. 2006; 27(9):1883-93. DOI: 10.1093/carcin/bgl041. View

17.

Hallek M, Cheson B, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H . Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008; 111(12):5446-56. PMC: 2972576. DOI: 10.1182/blood-2007-06-093906. View

18.

Li A, Dubey S, Varney M, Dave B, Singh R . IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003; 170(6):3369-76. DOI: 10.4049/jimmunol.170.6.3369. View

19.

Yu Z, Sun B, Kantarjian H, Keating M, Amin H, Sun X . Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators. Leuk Lymphoma. 2008; 49(4):751-6. DOI: 10.1080/10428190801888696. View

20.

Menzel T, Rahman Z, Calleja E, White K, Wilson E, Wieder R . Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood. 1996; 87(3):1056-63. View